Artelo Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Artelo Biosciences generated cash of -$6,141,000, which is less than the previous year. Cash used in financing activities reached the amount of $14,112,000 last year. Net change in cash is therefore $4,487,000.
Cash Flow
| 2014 | -15.26K | 0 | 30K |
|---|---|---|---|
| 2016 | -18.48K | 0 | 5.05K |
| 2018 | -1.61M | -845 | 1.38M |
| 2020 | -4.34M | 0 | 1.98M |
| 2021 | -6.14M | -3.43M | 14.11M |
ARTL Cash Flow Statement (2014 – 2021)
| 2021 | 2020 | 2018 | 2016 | 2014 | |
|---|---|---|---|---|---|
Cash at beginning of period | 2.14M | 4.42M | 572.77K | 17.02K | 0 |
Operating activities | |||||
Net income | -7.43M | -4.65M | -2.34M | -29.69K | -15.26K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 500 | 282 | 0 | 0 |
Stock-based compensation expense | 1.53M | 377.76K | 290.00K | 0 | 0 |
| Deferred income tax benefit | 1.53M | 377.76K | 290.00K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3K | 127.97K | 500.69K | 11.20K | 0 |
Cash generated by operating activities | -6.14M | -4.34M | -1.61M | -18.48K | -15.26K |
Investing activities | |||||
Purchases Of Investments | -3.43M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -845 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -3.43M | 0 | -845 | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 8.10M | 1.97M | 1.38M | 0 | 30K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -108 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 14.11M | 1.98M | 1.38M | 5.05K | 30K |
Net Change In Cash | 4.48M | -2.28M | -235.35K | -13.43K | 14.73K |
Cash at end of period | 6.62M | 2.14M | 337.42K | 3.59K | 14.73K |
| Data source | Data source | Data source | Data source |